France. Pathway, the data company that builds live AI, has raised $10 million seed funding to build live AI systems that think and learn in real-time as humans do. 

The round was led by TQ Ventures, with participation from Kadmos, Inovo, Market One Capital and Id4, as well as several high-profile angel investors. They join notable previous investors, including Lukasz Kaiser, the company’s very first backer, who is the co-author of Transformers (the “T” in ChatGPT) and the key researcher behind GPT o1 from OpenAI.

Wexler AI, the AI-powered legal fact intelligence platform, has completed a $1.4 million pre-seed funding round led by Myriad Venture Partners, with support from Entrepreneur First, and prominent angel investors at ComplyAdvantage, Moonpig, Tractable, and CreditKudos, fueling Wexler's growth and mission to redefine litigation worldwide.

Newcells Biotech - whose laboratory models help speed up drug development and reduce reliance on animal testing - has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance.

Bleap has announced a £1.8 million pre-seed round to launch a self-custodial payments app enabling customers to spend stablecoins 1:1 with a debit card, with no fees and up to 2% cashback on purchases.

Carbon utilisation company Barton Blakeley has raised £2.4m in a funding round, with £1.7m of this coming from Elbow Beach Capital, a seed investor in climate-related technologies.

Stackfix, the AI-powered software comparison platform, has raised $3M in Seed funding to speed-up software buying for small businesses globally.

Chalfen Ventures led the round, with participation from Seedcamp and helloworld, alongside prominent angel investors such as Paul Forster (Founder of Indeed.com), Mehdi Ghissassi (Head of Product at DeepMind), Matt Clifford (Chair of Entrepreneur First and ARIA), Alice Bentinck (Co-Founder of Entrepreneur First), and Charlie Delingpole (Founder of ComplyAdvantage).

Qminder has secured €3 million in seed funding led by Practica Capital - its first investment in Estonia from its latest fund and Qminder's first institutional funding. The round also included Jaan Tallinn's Metaplanet, BADideas.fund syndicate, and strategic angel investors from Toggl, Veriff, Pipedrive, Wise, and Twilio.

The Invest in Women Taskforce has secured over £250 million of funding to support female entrepreneurs in the UK. This milestone exceeds the Taskforce's initial ambitious goal of creating one of the world's largest investment pools of £250 million for female-led and mixed businesses.

BGF has joined forces with other major investors, including Barclays, M&G, the British Business Bank, Morgan Stanley, the Visa Foundation and Aviva, to announce a commitment to invest in female-founded businesses across the country. Investments will either be made directly themselves or through the ‘Women backing Women' fund.

Northern Gritstone has led a £4 million seed investment in Sheffield University spinout Exciting Instruments alongside co-investors Empirical Ventures, NPIF II - Praetura Equity Finance, and serial entrepreneurs Stan Boland and Jonathan Millner.

Virtue Drinks, the UK's fastest-selling clean energy drink, has closed a £2m investment round, bringing its total funding to over £5m. This latest round includes investment from Eberechi Eze, Premier League footballer and England international, and James Watt, co-founder of BrewDog.

Eden AI has raised €3 million in its latest seed round. This funding, led by Galion.exe with participation from 50 Partners and prominent business angels like Olivier Pomel (Co-Founder of Datadog), Sébastien Pahl (Co-Founder of Docker), and Alix de Sagazan (Co-Founder of ABTasty), marks a pivotal step forward in Edenn AI's mission to revolutionize AI integration for businesses.

Chiron Health AI, a health-tech startup which provides a breakthrough model in chronic disease management, has announced the successful completion of its pre-seed funding round, led by SFC Capital. The funding will enable Chiron Health AI to accelerate the launch of its fully integrated B2B product for healthcare payers, providers and pharma, and to develop a new data-driven self-care pathway designed to sit alongside medical care.